Search the Newsreel

BioAge's BGE-102 Enters Obesity Trial; Eye Study Planned

BioAge Labs reported a Q2 2026 net loss of $26.1 million on collaboration revenue of $2.4 million, with increased R&D expenses driven by its BGE-102 program. The company has dosed the first participant in its Phase 2 QUELL-CV trial for obesity with inflammation, expecting …

Joseph B. Hayek and Suresh Krishna Join Apogee Enterprises’ Board of Directors

MINNEAPOLIS, August 05, 2026--(BUSINESS WIRE)--Apogee Enterprises, Inc. (Nasdaq: APOG), a leading provider of architectural building products and services, as well as high-performance coated materials used in a variety of applications, announced today that its Board of Directors has elected Joseph B. Hayek, President and …

Thinkific Labs Inc. Provides Earnings Guidance for the Third Quarter of 2026

Astera Labs Stock Strategy Etches Path Toward A Large Return Or Discounted Shares

Astera Labs stock spiked 12.7% on Tuesday after the company surpassed Wall Street's targets in its latest earnings announcement. Investors could buy Astera Labs at the current price or use options to potentially buy shares of the semiconductor company for a discount. Astera Labs …

Proto Labs (PRLB) insider Kenison plans $947K stock sale in Form 144

Proto Labs (PRLB) shareholder Michael R. Kenison has filed a Form 144, indicating a planned sale of 10,753 shares of common stock valued at approximately $947,786.62 through Morgan Stanley Smith Barney LLC on the NYSE. The filing also details Kenison's prior acquisitions through restricted …

Can Microchip's Micron Alliance Help it Challenge AVGO & ALAB?

Microchip Technology MCHP announced on Tuesday (Aug. 4) that it will showcase an end-to-end PCIe Gen 6 storage architecture, which combines its Switchtec PCIe Gen 6 switches with Micron's MU 9650 NVMe solid-state drives (SSDs). The architecture will strengthen MCHP's prospects in the rapidly …

Nano Labs (Nasdaq: NA) approved as Validator Node on Canton Network

Nano Labs (Nasdaq: NA) has been approved as a Validator Node on the Canton Network, an institutional-grade blockchain network. This move integrates Nano Labs into a global ecosystem alongside major financial institutions, strengthening its strategy in digital asset infrastructure and blockchain-based financial solutions. The …

Nano Labs joins Canton Network validator consortium alongside major financial institutions

Nano Labs has joined the Canton Network as a validator node, integrating with an institutional blockchain consortium that includes major financial firms. This move positions Nano Labs to support institutional digital-asset applications, such as settlement workflows and on-chain asset management. The Canton Network prioritizes …

Nano Labs Approved to Join Canton Network, Which Includes Goldman Sachs and Visa

Nano Labs (Nasdaq: NA) has been approved to join the Canton Network as a Validator Node, integrating it into an institutional-grade blockchain ecosystem alongside global financial institutions like Goldman Sachs and Visa. This move is a key step in Nano Labs' strategy to develop …

Astera Labs Q2 Earnings Beat on PCIe 6 and Scorpio Strength

Astera Labs ALAB reported second-quarter 2026 non-GAAP earnings of 80 cents per share, up 81.8% year over year. The figure beat the Zacks Consensus Estimate by 15.94%. Revenues surged 104.4% year over year to $392.4 million, surpassing the Zacks Consensus Estimate by 8.93%. Broad-based …

ALAB Q2 Earnings Call Puts Scorpio Ramp Ahead of Schedule

Astera Labs, Inc. ALAB centered its second-quarter 2026 earnings call on an earlier-than-expected production ramp for Scorpio fabric switches and a sharp third-quarter revenue step-up. Management also widened the growth narrative beyond switching, pointing to sustained Aries demand, new CXL wins, optical connectivity and …

Astera Labs Sees Revenue Jumping 40% Next Quarter

This article first appeared on GuruFocus. Astera Labs (NASDAQ:ALAB), which makes connectivity semiconductors for AI data center racks, rose 1.94% premarket after reporting second-quarter revenue up 104% to a record $392.4 million, ahead of the $360.85 million analysts expected, with non-GAAP earnings of $0.80 …

Price to earnings forward of BioAge Labs, Inc. – SWB:Y7G

This article provides financial information for BioAge Labs, Inc. (SWB:Y7G), specifically focusing on its price-to-earnings forward metric. The content includes a brief mention of the period, value, and change associated with this financial indicator.

Astera Labs, Inc. (ALAB) regains ground in a mixed weekly semiconductor setup

The rebound matters because the cloud and AI connectivity chip stock is still working through conflicting weekly momentum signals.

Amazon’s AWS CEO Just Sent Shivers Down the Spines of AI Bears. Supply is Mostly ‘Spoken For’ Through 2028.

Quick Read Garman declared AWS capacity "spoken for" through 2028, and AMZN posted 37% growth, its fastest in 18 quarters, with shares surging 20% in five sessions. AWS's AI and Chips businesses each eclipsed $25 billion run rates at triple-digit growth, with UBS projecting …

Astera Labs Inc reports results for the quarter ended June 30 - Earnings Summary

Astera Labs Inc has released its earnings summary for the quarter that ended on June 30. The article is a brief announcement from Reuters, indicating the availability of the full report for subscribers on TradingView.

Quantum X-Labs Advances Quantum Computing for Nuclear Particle Transport prediction

The technology aims to translate the physical transport model into a quantum circuit Tel Aviv, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Quantum X Labs Inc. (Nasdaq: QXL) (“Quantum X” or the “Company”), an advanced technologies company, today announced that its subsidiary, Nuclear Quantum, has …

NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B

The New York Stock Exchange (NYSE) provides a daily pre-market update, highlighting Expedition Therapeutics' $115 million Series B funding and its CEO's upcoming appearance on NYSE Live. The update also mentions record highs for the Dow Jones Industrial Average and S&P 500, along with …

Astera Labs price target raised to $450 from $270 at Jefferies

Jefferies analyst Blayne Curtis increased the price target for Astera Labs (ALAB) to $450 from $270, maintaining a Buy rating on the shares. This upgrade follows Astera Labs' strong Q2 performance and a "substantial" Q3 earnings guidance raise, which is 50% above consensus estimates. …

Earnings To Watch: Blend Labs Inc (BLND) Q2 2026 -- GF Value Sees 86% Upside

Haleos Labs reappoints Mannam Malakondaiah and Srinivas Samavedam as directors

Haleos Labs' Material Subsidiary Mahi Drugs Appoints Vincent P. Asaro as Nominee Director, Names New Cost Auditors

Lo que hay que saber: Los analistas se muestran mucho más optimistas respecto a Astera Labs, Inc. (NASDAQ:ALAB)

Need To Know: Analysts Are Much More Bullish On Astera Labs, Inc. (NASDAQ:ALAB)

BioAge Labs, Inc. (BIOA) Reports Q2 Loss, Beats Revenue Estimates

Haleos Labs Q1 Results: Standalone Profit Rises 45% QoQ To ₹3.24 Cr

Quantum X Labs Seeks to Encode Gamma-Photon Histories

Aurora Labs Wins Key Aerospace Quality Certification to Unlock Defence Supply Chains

Thinkific Labs Inc. 2026 Q2 - Results - Earnings Call Presentation (TSX:THNC:CA) 2026-08-05

Astera Labs Inc (ALAB) (Q2 2026) Earnings Call Highlights: Record Revenue and Scorpio-X Ramp ...

This article first appeared on GuruFocus. Revenue: Record revenue of $392.4 million, up 27% sequentially and 104% year over year. Gross Margin: Non-GAAP gross margin was 73.7%, above guidance of 73%. Operating Expenses: Non-GAAP operating expenses were $135.8 million, up 10% sequentially. Operating Margin: …

SPCX, AMD, NVDA, ALAB, AMIX: 5 Trending Stocks Today - Advanced Micro Devices (NASDAQ:AMD)

On Tuesday, major U.S. stock indexes closed higher, with the Dow Jones, S&P 500, and Nasdaq all seeing significant gains. This article highlights five trending stocks that captured investor attention: SpaceX (SPCX), Advanced Micro Devices (AMD), Nvidia (NVDA), Astera Labs (ALAB), and Autonomix Medical …

H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16

H.C. Wainwright has reiterated its Buy rating for Absci Corp (ABSI.US) and maintained a target price of $16. This indicates the firm's continued confidence in the company's stock performance. Investors will likely view this as a positive signal regarding Absci's future outlook.

Astera Labs (ALAB) Is Up 40.6% After Record Q2 Results And Scorpio X-Series Ramp - What's Changed

Astera Labs recently reported record second-quarter 2026 revenue and strong guidance for the third quarter, highlighting accelerating demand for its AI infrastructure connectivity portfolio and the volume-production ramp of its Scorpio X-Series fabric switches. Alongside these results, the company expanded its Taiwan operations and …

Astera Labs, Inc. (ALAB) Beats Q2 Earnings and Revenue Estimates

Astera Labs, Inc. (ALAB) came out with quarterly earnings of $0.8 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.44 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

Astera Labs Stock Shoots Higher After Q2 Earnings — Here's Why

Astera Labs (NASDAQ:ALAB) reported impressive Q2 2026 earnings, surpassing analyst expectations for both revenue and adjusted earnings per share. The company posted a record revenue of $392.4 million, demonstrating significant sequential and year-over-year growth, driven by strong performance across its product portfolio. Following the …

Informe de resultados de Astera Labs: BPA del segundo trimestre supera previsiones